nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—CYP3A4—bone cancer	0.596	1	CbGaD
Bromocriptine—HTR1B—dura mater—bone cancer	0.0189	0.168	CbGeAlD
Bromocriptine—HTR1D—dura mater—bone cancer	0.0183	0.162	CbGeAlD
Bromocriptine—DRD5—eyelid—bone cancer	0.018	0.16	CbGeAlD
Bromocriptine—HTR1B—trigeminal nerve—bone cancer	0.00812	0.072	CbGeAlD
Bromocriptine—HTR1D—trigeminal nerve—bone cancer	0.00786	0.0697	CbGeAlD
Bromocriptine—HTR1B—cranial nerve—bone cancer	0.00578	0.0513	CbGeAlD
Bromocriptine—HTR1D—cranial nerve—bone cancer	0.0056	0.0497	CbGeAlD
Bromocriptine—HTR7—cranial nerve—bone cancer	0.00446	0.0396	CbGeAlD
Bromocriptine—HTR2A—trigeminal nerve—bone cancer	0.0039	0.0346	CbGeAlD
Bromocriptine—HTR2A—cranial nerve—bone cancer	0.00278	0.0247	CbGeAlD
Bromocriptine—HTR2A—vertebral column—bone cancer	0.00273	0.0242	CbGeAlD
Bromocriptine—Ergoloid mesylate—CYP3A4—bone cancer	0.00262	0.29	CrCbGaD
Bromocriptine—HTR2A—hindlimb—bone cancer	0.00234	0.0208	CbGeAlD
Bromocriptine—HTR2A—appendage—bone cancer	0.00201	0.0178	CbGeAlD
Bromocriptine—Dihydroergotamine—CYP3A4—bone cancer	0.00198	0.22	CrCbGaD
Bromocriptine—Ergonovine—CYP3A4—bone cancer	0.00181	0.201	CrCbGaD
Bromocriptine—Methylergometrine—CYP3A4—bone cancer	0.00159	0.176	CrCbGaD
Bromocriptine—HTR1D—connective tissue—bone cancer	0.00116	0.0103	CbGeAlD
Bromocriptine—ADRB1—connective tissue—bone cancer	0.00112	0.00997	CbGeAlD
Bromocriptine—Ergotamine—CYP3A4—bone cancer	0.00102	0.113	CrCbGaD
Bromocriptine—Pleural effusion—Epirubicin—bone cancer	0.00101	0.00562	CcSEcCtD
Bromocriptine—Amblyopia—Epirubicin—bone cancer	0.001	0.00558	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Cisplatin—bone cancer	0.000999	0.00556	CcSEcCtD
Bromocriptine—Cramp muscle—Cisplatin—bone cancer	0.000985	0.00548	CcSEcCtD
Bromocriptine—Nasopharyngitis—Cisplatin—bone cancer	0.000978	0.00544	CcSEcCtD
Bromocriptine—Dermatitis atopic—Doxorubicin—bone cancer	0.000967	0.00538	CcSEcCtD
Bromocriptine—Pleural effusion—Doxorubicin—bone cancer	0.000935	0.0052	CcSEcCtD
Bromocriptine—Amblyopia—Doxorubicin—bone cancer	0.000927	0.00516	CcSEcCtD
Bromocriptine—HTR7—connective tissue—bone cancer	0.000921	0.00817	CbGeAlD
Bromocriptine—Abdominal discomfort—Cisplatin—bone cancer	0.000906	0.00504	CcSEcCtD
Bromocriptine—Delirium—Epirubicin—bone cancer	0.000899	0.00501	CcSEcCtD
Bromocriptine—Vasculitis—Methotrexate—bone cancer	0.000847	0.00471	CcSEcCtD
Bromocriptine—Delirium—Doxorubicin—bone cancer	0.000832	0.00463	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Cisplatin—bone cancer	0.000831	0.00462	CcSEcCtD
Bromocriptine—Myocardial infarction—Cisplatin—bone cancer	0.000826	0.0046	CcSEcCtD
Bromocriptine—Dyskinesia—Epirubicin—bone cancer	0.000823	0.00458	CcSEcCtD
Bromocriptine—HTR1B—spinal cord—bone cancer	0.000791	0.00702	CbGeAlD
Bromocriptine—Ventricular tachycardia—Epirubicin—bone cancer	0.000774	0.00431	CcSEcCtD
Bromocriptine—Bradycardia—Cisplatin—bone cancer	0.00077	0.00429	CcSEcCtD
Bromocriptine—Dyskinesia—Doxorubicin—bone cancer	0.000762	0.00424	CcSEcCtD
Bromocriptine—HTR2C—spinal cord—bone cancer	0.000759	0.00673	CbGeAlD
Bromocriptine—Connective tissue disorder—Cisplatin—bone cancer	0.000743	0.00414	CcSEcCtD
Bromocriptine—HTR2B—tendon—bone cancer	0.000739	0.00656	CbGeAlD
Bromocriptine—Visual impairment—Cisplatin—bone cancer	0.000729	0.00406	CcSEcCtD
Bromocriptine—Ventricular tachycardia—Doxorubicin—bone cancer	0.000716	0.00398	CcSEcCtD
Bromocriptine—Cramps of lower extremities—Epirubicin—bone cancer	0.000711	0.00396	CcSEcCtD
Bromocriptine—Eye disorder—Cisplatin—bone cancer	0.000707	0.00394	CcSEcCtD
Bromocriptine—Tinnitus—Cisplatin—bone cancer	0.000705	0.00393	CcSEcCtD
Bromocriptine—Cardiac disorder—Cisplatin—bone cancer	0.000702	0.00391	CcSEcCtD
Bromocriptine—Diabetes mellitus—Methotrexate—bone cancer	0.00069	0.00384	CcSEcCtD
Bromocriptine—Mediastinal disorder—Cisplatin—bone cancer	0.000682	0.00379	CcSEcCtD
Bromocriptine—Arrhythmia—Cisplatin—bone cancer	0.000676	0.00376	CcSEcCtD
Bromocriptine—ADRA2A—connective tissue—bone cancer	0.000675	0.00599	CbGeAlD
Bromocriptine—Alopecia—Cisplatin—bone cancer	0.000668	0.00372	CcSEcCtD
Bromocriptine—Cramps of lower extremities—Doxorubicin—bone cancer	0.000658	0.00366	CcSEcCtD
Bromocriptine—Diabetes mellitus—Epirubicin—bone cancer	0.000646	0.00359	CcSEcCtD
Bromocriptine—HTR1A—spinal cord—bone cancer	0.000639	0.00567	CbGeAlD
Bromocriptine—Visual disturbance—Methotrexate—bone cancer	0.000633	0.00352	CcSEcCtD
Bromocriptine—Muscle spasms—Cisplatin—bone cancer	0.000633	0.00352	CcSEcCtD
Bromocriptine—HTR7—tendon—bone cancer	0.000633	0.00561	CbGeAlD
Bromocriptine—Vision blurred—Cisplatin—bone cancer	0.000621	0.00345	CcSEcCtD
Bromocriptine—Cardiac failure congestive—Epirubicin—bone cancer	0.000619	0.00345	CcSEcCtD
Bromocriptine—Lethargy—Methotrexate—bone cancer	0.000612	0.00341	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Methotrexate—bone cancer	0.000612	0.00341	CcSEcCtD
Bromocriptine—HTR7—spinal cord—bone cancer	0.00061	0.00542	CbGeAlD
Bromocriptine—Diabetes mellitus—Doxorubicin—bone cancer	0.000597	0.00333	CcSEcCtD
Bromocriptine—ADRA2C—tendon—bone cancer	0.000582	0.00516	CbGeAlD
Bromocriptine—Hypoglycaemia—Epirubicin—bone cancer	0.000575	0.0032	CcSEcCtD
Bromocriptine—HTR2A—connective tissue—bone cancer	0.000574	0.00509	CbGeAlD
Bromocriptine—Lethargy—Epirubicin—bone cancer	0.000573	0.00319	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Epirubicin—bone cancer	0.000573	0.00319	CcSEcCtD
Bromocriptine—Cardiac failure congestive—Doxorubicin—bone cancer	0.000573	0.00319	CcSEcCtD
Bromocriptine—Convulsion—Cisplatin—bone cancer	0.000571	0.00318	CcSEcCtD
Bromocriptine—Ataxia—Methotrexate—bone cancer	0.000564	0.00314	CcSEcCtD
Bromocriptine—Diplopia—Epirubicin—bone cancer	0.000562	0.00313	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.000562	0.00313	CcSEcCtD
Bromocriptine—ADRA2C—spinal cord—bone cancer	0.000561	0.00498	CbGeAlD
Bromocriptine—Anxiety—Cisplatin—bone cancer	0.000559	0.00311	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000557	0.0031	CcSEcCtD
Bromocriptine—Oedema—Cisplatin—bone cancer	0.000537	0.00299	CcSEcCtD
Bromocriptine—Infection—Cisplatin—bone cancer	0.000534	0.00297	CcSEcCtD
Bromocriptine—Hypoglycaemia—Doxorubicin—bone cancer	0.000532	0.00296	CcSEcCtD
Bromocriptine—Lethargy—Doxorubicin—bone cancer	0.00053	0.00295	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Doxorubicin—bone cancer	0.00053	0.00295	CcSEcCtD
Bromocriptine—Ataxia—Epirubicin—bone cancer	0.000528	0.00294	CcSEcCtD
Bromocriptine—Nervous system disorder—Cisplatin—bone cancer	0.000527	0.00293	CcSEcCtD
Bromocriptine—Tachycardia—Cisplatin—bone cancer	0.000525	0.00292	CcSEcCtD
Bromocriptine—Skin disorder—Cisplatin—bone cancer	0.000522	0.00291	CcSEcCtD
Bromocriptine—Diplopia—Doxorubicin—bone cancer	0.00052	0.00289	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.00052	0.00289	CcSEcCtD
Bromocriptine—Abdominal pain upper—Epirubicin—bone cancer	0.000513	0.00285	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Epirubicin—bone cancer	0.000513	0.00285	CcSEcCtD
Bromocriptine—Anorexia—Cisplatin—bone cancer	0.000512	0.00285	CcSEcCtD
Bromocriptine—Hypotension—Cisplatin—bone cancer	0.000502	0.0028	CcSEcCtD
Bromocriptine—Nasopharyngitis—Epirubicin—bone cancer	0.000502	0.0028	CcSEcCtD
Bromocriptine—Abdominal discomfort—Methotrexate—bone cancer	0.000497	0.00277	CcSEcCtD
Bromocriptine—Ataxia—Doxorubicin—bone cancer	0.000489	0.00272	CcSEcCtD
Bromocriptine—Influenza—Epirubicin—bone cancer	0.000485	0.0027	CcSEcCtD
Bromocriptine—Dysphagia—Epirubicin—bone cancer	0.000485	0.0027	CcSEcCtD
Bromocriptine—Paraesthesia—Cisplatin—bone cancer	0.000483	0.00269	CcSEcCtD
Bromocriptine—Dyspnoea—Cisplatin—bone cancer	0.000479	0.00267	CcSEcCtD
Bromocriptine—Abdominal pain upper—Doxorubicin—bone cancer	0.000475	0.00264	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Doxorubicin—bone cancer	0.000475	0.00264	CcSEcCtD
Bromocriptine—Decreased appetite—Cisplatin—bone cancer	0.000467	0.0026	CcSEcCtD
Bromocriptine—Nasopharyngitis—Doxorubicin—bone cancer	0.000465	0.00259	CcSEcCtD
Bromocriptine—ADRA2A—tendon—bone cancer	0.000464	0.00412	CbGeAlD
Bromocriptine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000464	0.00258	CcSEcCtD
Bromocriptine—Drowsiness—Methotrexate—bone cancer	0.000462	0.00257	CcSEcCtD
Bromocriptine—Influenza—Doxorubicin—bone cancer	0.000449	0.0025	CcSEcCtD
Bromocriptine—Dysphagia—Doxorubicin—bone cancer	0.000449	0.0025	CcSEcCtD
Bromocriptine—Pollakiuria—Epirubicin—bone cancer	0.000448	0.0025	CcSEcCtD
Bromocriptine—ADRA2A—spinal cord—bone cancer	0.000448	0.00397	CbGeAlD
Bromocriptine—Feeling abnormal—Cisplatin—bone cancer	0.000443	0.00247	CcSEcCtD
Bromocriptine—Drowsiness—Epirubicin—bone cancer	0.000433	0.00241	CcSEcCtD
Bromocriptine—Body temperature increased—Cisplatin—bone cancer	0.000425	0.00236	CcSEcCtD
Bromocriptine—Pollakiuria—Doxorubicin—bone cancer	0.000415	0.00231	CcSEcCtD
Bromocriptine—Sinusitis—Epirubicin—bone cancer	0.000406	0.00226	CcSEcCtD
Bromocriptine—Drowsiness—Doxorubicin—bone cancer	0.0004	0.00223	CcSEcCtD
Bromocriptine—Visual impairment—Methotrexate—bone cancer	0.0004	0.00223	CcSEcCtD
Bromocriptine—Bradycardia—Epirubicin—bone cancer	0.000395	0.0022	CcSEcCtD
Bromocriptine—HTR2A—tendon—bone cancer	0.000395	0.0035	CbGeAlD
Bromocriptine—Rhinitis—Epirubicin—bone cancer	0.000389	0.00217	CcSEcCtD
Bromocriptine—Eye disorder—Methotrexate—bone cancer	0.000388	0.00216	CcSEcCtD
Bromocriptine—Tinnitus—Methotrexate—bone cancer	0.000387	0.00215	CcSEcCtD
Bromocriptine—Hypoaesthesia—Epirubicin—bone cancer	0.000387	0.00215	CcSEcCtD
Bromocriptine—Asthenia—Cisplatin—bone cancer	0.000386	0.00215	CcSEcCtD
Bromocriptine—Cardiac disorder—Methotrexate—bone cancer	0.000385	0.00214	CcSEcCtD
Bromocriptine—Oedema peripheral—Epirubicin—bone cancer	0.000383	0.00213	CcSEcCtD
Bromocriptine—Connective tissue disorder—Epirubicin—bone cancer	0.000382	0.00212	CcSEcCtD
Bromocriptine—HTR2A—spinal cord—bone cancer	0.000381	0.00338	CbGeAlD
Bromocriptine—Angiopathy—Methotrexate—bone cancer	0.000377	0.0021	CcSEcCtD
Bromocriptine—Sinusitis—Doxorubicin—bone cancer	0.000376	0.00209	CcSEcCtD
Bromocriptine—Visual impairment—Epirubicin—bone cancer	0.000374	0.00208	CcSEcCtD
Bromocriptine—Mediastinal disorder—Methotrexate—bone cancer	0.000374	0.00208	CcSEcCtD
Bromocriptine—Diarrhoea—Cisplatin—bone cancer	0.000368	0.00205	CcSEcCtD
Bromocriptine—Alopecia—Methotrexate—bone cancer	0.000367	0.00204	CcSEcCtD
Bromocriptine—Bradycardia—Doxorubicin—bone cancer	0.000366	0.00204	CcSEcCtD
Bromocriptine—Mental disorder—Methotrexate—bone cancer	0.000364	0.00202	CcSEcCtD
Bromocriptine—Eye disorder—Epirubicin—bone cancer	0.000363	0.00202	CcSEcCtD
Bromocriptine—Tinnitus—Epirubicin—bone cancer	0.000362	0.00202	CcSEcCtD
Bromocriptine—Cardiac disorder—Epirubicin—bone cancer	0.000361	0.00201	CcSEcCtD
Bromocriptine—Rhinitis—Doxorubicin—bone cancer	0.00036	0.00201	CcSEcCtD
Bromocriptine—Hypoaesthesia—Doxorubicin—bone cancer	0.000358	0.00199	CcSEcCtD
Bromocriptine—Oedema peripheral—Doxorubicin—bone cancer	0.000354	0.00197	CcSEcCtD
Bromocriptine—Dysgeusia—Methotrexate—bone cancer	0.000354	0.00197	CcSEcCtD
Bromocriptine—Connective tissue disorder—Doxorubicin—bone cancer	0.000353	0.00197	CcSEcCtD
Bromocriptine—Angiopathy—Epirubicin—bone cancer	0.000352	0.00196	CcSEcCtD
Bromocriptine—Mediastinal disorder—Epirubicin—bone cancer	0.00035	0.00195	CcSEcCtD
Bromocriptine—Arrhythmia—Epirubicin—bone cancer	0.000347	0.00193	CcSEcCtD
Bromocriptine—Visual impairment—Doxorubicin—bone cancer	0.000346	0.00193	CcSEcCtD
Bromocriptine—Alopecia—Epirubicin—bone cancer	0.000343	0.00191	CcSEcCtD
Bromocriptine—Vomiting—Cisplatin—bone cancer	0.000342	0.0019	CcSEcCtD
Bromocriptine—Vision blurred—Methotrexate—bone cancer	0.000341	0.0019	CcSEcCtD
Bromocriptine—Mental disorder—Epirubicin—bone cancer	0.00034	0.00189	CcSEcCtD
Bromocriptine—Rash—Cisplatin—bone cancer	0.000339	0.00189	CcSEcCtD
Bromocriptine—Dermatitis—Cisplatin—bone cancer	0.000339	0.00188	CcSEcCtD
Bromocriptine—Eye disorder—Doxorubicin—bone cancer	0.000336	0.00187	CcSEcCtD
Bromocriptine—Tinnitus—Doxorubicin—bone cancer	0.000335	0.00187	CcSEcCtD
Bromocriptine—Cardiac disorder—Doxorubicin—bone cancer	0.000334	0.00186	CcSEcCtD
Bromocriptine—Tension—Epirubicin—bone cancer	0.000332	0.00185	CcSEcCtD
Bromocriptine—Dysgeusia—Epirubicin—bone cancer	0.000331	0.00184	CcSEcCtD
Bromocriptine—Nervousness—Epirubicin—bone cancer	0.000328	0.00183	CcSEcCtD
Bromocriptine—Angiopathy—Doxorubicin—bone cancer	0.000326	0.00182	CcSEcCtD
Bromocriptine—Muscle spasms—Epirubicin—bone cancer	0.000325	0.00181	CcSEcCtD
Bromocriptine—Vertigo—Methotrexate—bone cancer	0.000325	0.00181	CcSEcCtD
Bromocriptine—Mediastinal disorder—Doxorubicin—bone cancer	0.000324	0.0018	CcSEcCtD
Bromocriptine—Arrhythmia—Doxorubicin—bone cancer	0.000321	0.00179	CcSEcCtD
Bromocriptine—Nausea—Cisplatin—bone cancer	0.000319	0.00178	CcSEcCtD
Bromocriptine—Vision blurred—Epirubicin—bone cancer	0.000319	0.00177	CcSEcCtD
Bromocriptine—Alopecia—Doxorubicin—bone cancer	0.000318	0.00177	CcSEcCtD
Bromocriptine—Mental disorder—Doxorubicin—bone cancer	0.000315	0.00175	CcSEcCtD
Bromocriptine—Convulsion—Methotrexate—bone cancer	0.000313	0.00174	CcSEcCtD
Bromocriptine—Agitation—Epirubicin—bone cancer	0.000311	0.00173	CcSEcCtD
Bromocriptine—Tension—Doxorubicin—bone cancer	0.000307	0.00171	CcSEcCtD
Bromocriptine—Dysgeusia—Doxorubicin—bone cancer	0.000306	0.00171	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000306	0.0017	CcSEcCtD
Bromocriptine—Nervousness—Doxorubicin—bone cancer	0.000304	0.00169	CcSEcCtD
Bromocriptine—Vertigo—Epirubicin—bone cancer	0.000304	0.00169	CcSEcCtD
Bromocriptine—Syncope—Epirubicin—bone cancer	0.000303	0.00169	CcSEcCtD
Bromocriptine—Muscle spasms—Doxorubicin—bone cancer	0.000301	0.00167	CcSEcCtD
Bromocriptine—Confusional state—Methotrexate—bone cancer	0.000297	0.00166	CcSEcCtD
Bromocriptine—Loss of consciousness—Epirubicin—bone cancer	0.000297	0.00165	CcSEcCtD
Bromocriptine—Vision blurred—Doxorubicin—bone cancer	0.000295	0.00164	CcSEcCtD
Bromocriptine—Convulsion—Epirubicin—bone cancer	0.000293	0.00163	CcSEcCtD
Bromocriptine—Infection—Methotrexate—bone cancer	0.000293	0.00163	CcSEcCtD
Bromocriptine—Hypertension—Epirubicin—bone cancer	0.000292	0.00163	CcSEcCtD
Bromocriptine—Nervous system disorder—Methotrexate—bone cancer	0.000289	0.00161	CcSEcCtD
Bromocriptine—Agitation—Doxorubicin—bone cancer	0.000288	0.0016	CcSEcCtD
Bromocriptine—Anxiety—Epirubicin—bone cancer	0.000287	0.0016	CcSEcCtD
Bromocriptine—Skin disorder—Methotrexate—bone cancer	0.000286	0.00159	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000286	0.00159	CcSEcCtD
Bromocriptine—Dry mouth—Epirubicin—bone cancer	0.000282	0.00157	CcSEcCtD
Bromocriptine—Vertigo—Doxorubicin—bone cancer	0.000281	0.00156	CcSEcCtD
Bromocriptine—Anorexia—Methotrexate—bone cancer	0.000281	0.00156	CcSEcCtD
Bromocriptine—Syncope—Doxorubicin—bone cancer	0.000281	0.00156	CcSEcCtD
Bromocriptine—Confusional state—Epirubicin—bone cancer	0.000278	0.00155	CcSEcCtD
Bromocriptine—Oedema—Epirubicin—bone cancer	0.000276	0.00154	CcSEcCtD
Bromocriptine—Hypotension—Methotrexate—bone cancer	0.000276	0.00153	CcSEcCtD
Bromocriptine—Loss of consciousness—Doxorubicin—bone cancer	0.000275	0.00153	CcSEcCtD
Bromocriptine—Infection—Epirubicin—bone cancer	0.000274	0.00153	CcSEcCtD
Bromocriptine—Shock—Epirubicin—bone cancer	0.000272	0.00151	CcSEcCtD
Bromocriptine—Convulsion—Doxorubicin—bone cancer	0.000271	0.00151	CcSEcCtD
Bromocriptine—Nervous system disorder—Epirubicin—bone cancer	0.000271	0.00151	CcSEcCtD
Bromocriptine—Hypertension—Doxorubicin—bone cancer	0.00027	0.0015	CcSEcCtD
Bromocriptine—Tachycardia—Epirubicin—bone cancer	0.000269	0.0015	CcSEcCtD
Bromocriptine—Skin disorder—Epirubicin—bone cancer	0.000268	0.00149	CcSEcCtD
Bromocriptine—Insomnia—Methotrexate—bone cancer	0.000267	0.00148	CcSEcCtD
Bromocriptine—Anxiety—Doxorubicin—bone cancer	0.000265	0.00148	CcSEcCtD
Bromocriptine—Paraesthesia—Methotrexate—bone cancer	0.000265	0.00147	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000265	0.00147	CcSEcCtD
Bromocriptine—Anorexia—Epirubicin—bone cancer	0.000263	0.00146	CcSEcCtD
Bromocriptine—Dyspnoea—Methotrexate—bone cancer	0.000263	0.00146	CcSEcCtD
Bromocriptine—Somnolence—Methotrexate—bone cancer	0.000262	0.00146	CcSEcCtD
Bromocriptine—Dry mouth—Doxorubicin—bone cancer	0.000261	0.00145	CcSEcCtD
Bromocriptine—Dyspepsia—Methotrexate—bone cancer	0.00026	0.00145	CcSEcCtD
Bromocriptine—Hypotension—Epirubicin—bone cancer	0.000258	0.00144	CcSEcCtD
Bromocriptine—Confusional state—Doxorubicin—bone cancer	0.000257	0.00143	CcSEcCtD
Bromocriptine—Decreased appetite—Methotrexate—bone cancer	0.000256	0.00143	CcSEcCtD
Bromocriptine—Oedema—Doxorubicin—bone cancer	0.000255	0.00142	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000255	0.00142	CcSEcCtD
Bromocriptine—Fatigue—Methotrexate—bone cancer	0.000254	0.00142	CcSEcCtD
Bromocriptine—Infection—Doxorubicin—bone cancer	0.000254	0.00141	CcSEcCtD
Bromocriptine—Shock—Doxorubicin—bone cancer	0.000251	0.0014	CcSEcCtD
Bromocriptine—ABCB1—bone marrow—bone cancer	0.00025	0.00222	CbGeAlD
Bromocriptine—Nervous system disorder—Doxorubicin—bone cancer	0.00025	0.00139	CcSEcCtD
Bromocriptine—Insomnia—Epirubicin—bone cancer	0.00025	0.00139	CcSEcCtD
Bromocriptine—ABCB1—spinal cord—bone cancer	0.000249	0.00221	CbGeAlD
Bromocriptine—Tachycardia—Doxorubicin—bone cancer	0.000249	0.00139	CcSEcCtD
Bromocriptine—Skin disorder—Doxorubicin—bone cancer	0.000248	0.00138	CcSEcCtD
Bromocriptine—Paraesthesia—Epirubicin—bone cancer	0.000248	0.00138	CcSEcCtD
Bromocriptine—Dyspnoea—Epirubicin—bone cancer	0.000246	0.00137	CcSEcCtD
Bromocriptine—Somnolence—Epirubicin—bone cancer	0.000245	0.00137	CcSEcCtD
Bromocriptine—Anorexia—Doxorubicin—bone cancer	0.000243	0.00135	CcSEcCtD
Bromocriptine—Feeling abnormal—Methotrexate—bone cancer	0.000243	0.00135	CcSEcCtD
Bromocriptine—Dyspepsia—Epirubicin—bone cancer	0.000243	0.00135	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Methotrexate—bone cancer	0.000241	0.00134	CcSEcCtD
Bromocriptine—Decreased appetite—Epirubicin—bone cancer	0.00024	0.00134	CcSEcCtD
Bromocriptine—Hypotension—Doxorubicin—bone cancer	0.000239	0.00133	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000238	0.00133	CcSEcCtD
Bromocriptine—Fatigue—Epirubicin—bone cancer	0.000238	0.00132	CcSEcCtD
Bromocriptine—Constipation—Epirubicin—bone cancer	0.000236	0.00131	CcSEcCtD
Bromocriptine—Urticaria—Methotrexate—bone cancer	0.000234	0.0013	CcSEcCtD
Bromocriptine—Body temperature increased—Methotrexate—bone cancer	0.000233	0.0013	CcSEcCtD
Bromocriptine—Abdominal pain—Methotrexate—bone cancer	0.000233	0.0013	CcSEcCtD
Bromocriptine—Insomnia—Doxorubicin—bone cancer	0.000231	0.00129	CcSEcCtD
Bromocriptine—Paraesthesia—Doxorubicin—bone cancer	0.000229	0.00128	CcSEcCtD
Bromocriptine—Dyspnoea—Doxorubicin—bone cancer	0.000228	0.00127	CcSEcCtD
Bromocriptine—Feeling abnormal—Epirubicin—bone cancer	0.000227	0.00127	CcSEcCtD
Bromocriptine—Somnolence—Doxorubicin—bone cancer	0.000227	0.00126	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Epirubicin—bone cancer	0.000226	0.00126	CcSEcCtD
Bromocriptine—Dyspepsia—Doxorubicin—bone cancer	0.000225	0.00125	CcSEcCtD
Bromocriptine—Decreased appetite—Doxorubicin—bone cancer	0.000222	0.00124	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00022	0.00123	CcSEcCtD
Bromocriptine—Fatigue—Doxorubicin—bone cancer	0.00022	0.00123	CcSEcCtD
Bromocriptine—Urticaria—Epirubicin—bone cancer	0.000219	0.00122	CcSEcCtD
Bromocriptine—Constipation—Doxorubicin—bone cancer	0.000218	0.00122	CcSEcCtD
Bromocriptine—Body temperature increased—Epirubicin—bone cancer	0.000218	0.00121	CcSEcCtD
Bromocriptine—Abdominal pain—Epirubicin—bone cancer	0.000218	0.00121	CcSEcCtD
Bromocriptine—Asthenia—Methotrexate—bone cancer	0.000212	0.00118	CcSEcCtD
Bromocriptine—Feeling abnormal—Doxorubicin—bone cancer	0.00021	0.00117	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000209	0.00116	CcSEcCtD
Bromocriptine—Urticaria—Doxorubicin—bone cancer	0.000203	0.00113	CcSEcCtD
Bromocriptine—Abdominal pain—Doxorubicin—bone cancer	0.000202	0.00112	CcSEcCtD
Bromocriptine—Body temperature increased—Doxorubicin—bone cancer	0.000202	0.00112	CcSEcCtD
Bromocriptine—Diarrhoea—Methotrexate—bone cancer	0.000202	0.00112	CcSEcCtD
Bromocriptine—Asthenia—Epirubicin—bone cancer	0.000198	0.0011	CcSEcCtD
Bromocriptine—Dizziness—Methotrexate—bone cancer	0.000195	0.00109	CcSEcCtD
Bromocriptine—Diarrhoea—Epirubicin—bone cancer	0.000189	0.00105	CcSEcCtD
Bromocriptine—Vomiting—Methotrexate—bone cancer	0.000188	0.00104	CcSEcCtD
Bromocriptine—Rash—Methotrexate—bone cancer	0.000186	0.00104	CcSEcCtD
Bromocriptine—Dermatitis—Methotrexate—bone cancer	0.000186	0.00103	CcSEcCtD
Bromocriptine—Headache—Methotrexate—bone cancer	0.000185	0.00103	CcSEcCtD
Bromocriptine—Asthenia—Doxorubicin—bone cancer	0.000183	0.00102	CcSEcCtD
Bromocriptine—Dizziness—Epirubicin—bone cancer	0.000183	0.00102	CcSEcCtD
Bromocriptine—Vomiting—Epirubicin—bone cancer	0.000175	0.000977	CcSEcCtD
Bromocriptine—Nausea—Methotrexate—bone cancer	0.000175	0.000975	CcSEcCtD
Bromocriptine—Diarrhoea—Doxorubicin—bone cancer	0.000175	0.000973	CcSEcCtD
Bromocriptine—Rash—Epirubicin—bone cancer	0.000174	0.000969	CcSEcCtD
Bromocriptine—Dermatitis—Epirubicin—bone cancer	0.000174	0.000968	CcSEcCtD
Bromocriptine—Headache—Epirubicin—bone cancer	0.000173	0.000962	CcSEcCtD
Bromocriptine—Dizziness—Doxorubicin—bone cancer	0.000169	0.00094	CcSEcCtD
Bromocriptine—Nausea—Epirubicin—bone cancer	0.000164	0.000913	CcSEcCtD
Bromocriptine—Vomiting—Doxorubicin—bone cancer	0.000162	0.000904	CcSEcCtD
Bromocriptine—Rash—Doxorubicin—bone cancer	0.000161	0.000896	CcSEcCtD
Bromocriptine—Dermatitis—Doxorubicin—bone cancer	0.000161	0.000895	CcSEcCtD
Bromocriptine—Headache—Doxorubicin—bone cancer	0.00016	0.00089	CcSEcCtD
Bromocriptine—Nausea—Doxorubicin—bone cancer	0.000152	0.000844	CcSEcCtD
Bromocriptine—HTR7—Signaling Pathways—IGF1R—bone cancer	3.02e-05	0.000294	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IGF1R—bone cancer	3e-05	0.000292	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—ATF1—bone cancer	2.98e-05	0.00029	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—GNA11—bone cancer	2.97e-05	0.000289	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—ATF1—bone cancer	2.96e-05	0.000287	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SMO—bone cancer	2.95e-05	0.000287	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IGF1R—bone cancer	2.94e-05	0.000286	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TGFBR2—bone cancer	2.94e-05	0.000285	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—GNA11—bone cancer	2.92e-05	0.000284	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL3—bone cancer	2.91e-05	0.000283	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SMO—bone cancer	2.9e-05	0.000282	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IGF1R—bone cancer	2.89e-05	0.000281	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—GNA11—bone cancer	2.89e-05	0.000281	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL3—bone cancer	2.88e-05	0.00028	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—ATF1—bone cancer	2.85e-05	0.000277	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—KIT—bone cancer	2.84e-05	0.000276	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—ATF1—bone cancer	2.84e-05	0.000276	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SMO—bone cancer	2.84e-05	0.000276	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL3—bone cancer	2.78e-05	0.000271	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL3—bone cancer	2.77e-05	0.000269	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TGFBR2—bone cancer	2.77e-05	0.000269	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IGF1R—bone cancer	2.76e-05	0.000269	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—ATF1—bone cancer	2.76e-05	0.000269	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—GSTP1—bone cancer	2.75e-05	0.000268	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TGFBR2—bone cancer	2.73e-05	0.000266	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TGFBR2—bone cancer	2.73e-05	0.000266	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—ATF1—bone cancer	2.72e-05	0.000264	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—GNA11—bone cancer	2.7e-05	0.000262	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL3—bone cancer	2.69e-05	0.000262	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—BRAF—bone cancer	2.67e-05	0.00026	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—GNA11—bone cancer	2.65e-05	0.000258	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL3—bone cancer	2.65e-05	0.000258	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SMO—bone cancer	2.64e-05	0.000256	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—CYP3A4—bone cancer	2.62e-05	0.000254	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IGF1R—bone cancer	2.6e-05	0.000253	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—GNA11—bone cancer	2.6e-05	0.000252	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—EGFR—bone cancer	2.59e-05	0.000252	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IGF1R—bone cancer	2.57e-05	0.00025	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IGF1R—bone cancer	2.57e-05	0.00025	CbGpPWpGaD
Bromocriptine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.57e-05	0.000249	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—ATF1—bone cancer	2.51e-05	0.000244	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TGFBR2—bone cancer	2.49e-05	0.000242	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TGFBR2—bone cancer	2.47e-05	0.00024	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—ATF1—bone cancer	2.47e-05	0.00024	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL3—bone cancer	2.44e-05	0.000238	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—ATF1—bone cancer	2.41e-05	0.000235	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—GNA11—bone cancer	2.41e-05	0.000235	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL3—bone cancer	2.4e-05	0.000234	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TGFBR2—bone cancer	2.38e-05	0.000231	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TGFBR2—bone cancer	2.37e-05	0.00023	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL3—bone cancer	2.35e-05	0.000229	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IGF1R—bone cancer	2.34e-05	0.000228	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IGF1R—bone cancer	2.32e-05	0.000226	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TGFBR2—bone cancer	2.3e-05	0.000224	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ENO2—bone cancer	2.3e-05	0.000224	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	2.27e-05	0.00022	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—ATF1—bone cancer	2.24e-05	0.000218	CbGpPWpGaD
Bromocriptine—ADRA2B—Hemostasis—TP53—bone cancer	2.24e-05	0.000218	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IGF1R—bone cancer	2.24e-05	0.000218	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—MDM2—bone cancer	2.24e-05	0.000218	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—GSTP1—bone cancer	2.24e-05	0.000218	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IGF1R—bone cancer	2.23e-05	0.000217	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—KIT—bone cancer	2.19e-05	0.000213	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—KIT—bone cancer	2.19e-05	0.000213	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL3—bone cancer	2.19e-05	0.000213	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—KIT—bone cancer	2.18e-05	0.000212	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IGF1R—bone cancer	2.17e-05	0.000211	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—DHFR—bone cancer	2.13e-05	0.000208	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IGF1R—bone cancer	2.13e-05	0.000207	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—KIT—bone cancer	2.13e-05	0.000207	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—KIT—bone cancer	2.1e-05	0.000204	CbGpPWpGaD
Bromocriptine—ADRA2C—Hemostasis—TP53—bone cancer	2.09e-05	0.000204	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TGFBR2—bone cancer	2.09e-05	0.000203	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—BRAF—bone cancer	2.06e-05	0.000201	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—BRAF—bone cancer	2.06e-05	0.0002	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	2.06e-05	0.0002	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—BRAF—bone cancer	2.05e-05	0.000199	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	2.01e-05	0.000196	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—BRAF—bone cancer	2e-05	0.000195	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—KIT—bone cancer	2e-05	0.000195	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—EGFR—bone cancer	2e-05	0.000194	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—EGFR—bone cancer	2e-05	0.000194	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—GNA11—bone cancer	2e-05	0.000194	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—EGFR—bone cancer	1.98e-05	0.000193	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—BRAF—bone cancer	1.97e-05	0.000192	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IGF1R—bone cancer	1.97e-05	0.000191	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—JUN—bone cancer	1.95e-05	0.000189	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—EGFR—bone cancer	1.94e-05	0.000189	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IGF1R—bone cancer	1.93e-05	0.000188	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—EGFR—bone cancer	1.91e-05	0.000186	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IGF1R—bone cancer	1.89e-05	0.000184	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—MMP9—bone cancer	1.89e-05	0.000184	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—KIT—bone cancer	1.89e-05	0.000184	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—BRAF—bone cancer	1.88e-05	0.000183	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	1.87e-05	0.000182	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—KIT—bone cancer	1.86e-05	0.000181	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—KIT—bone cancer	1.86e-05	0.000181	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ENO2—bone cancer	1.84e-05	0.000179	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—EGFR—bone cancer	1.82e-05	0.000177	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CYP3A4—bone cancer	1.81e-05	0.000176	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—BRAF—bone cancer	1.78e-05	0.000173	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	1.76e-05	0.000171	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—BRAF—bone cancer	1.75e-05	0.00017	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—BRAF—bone cancer	1.75e-05	0.00017	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MDM2—bone cancer	1.73e-05	0.000168	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MDM2—bone cancer	1.73e-05	0.000168	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—EGFR—bone cancer	1.72e-05	0.000167	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MDM2—bone cancer	1.71e-05	0.000167	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—DHFR—bone cancer	1.7e-05	0.000166	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—TP53—bone cancer	1.7e-05	0.000165	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—KIT—bone cancer	1.7e-05	0.000165	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—EGFR—bone cancer	1.7e-05	0.000165	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—EGFR—bone cancer	1.7e-05	0.000165	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—KIT—bone cancer	1.68e-05	0.000164	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MDM2—bone cancer	1.68e-05	0.000163	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MDM2—bone cancer	1.65e-05	0.000161	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—KIT—bone cancer	1.62e-05	0.000158	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—KIT—bone cancer	1.62e-05	0.000157	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—BRAF—bone cancer	1.6e-05	0.000155	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GNA11—bone cancer	1.59e-05	0.000155	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—BRAF—bone cancer	1.58e-05	0.000154	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MDM2—bone cancer	1.58e-05	0.000153	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—KIT—bone cancer	1.57e-05	0.000153	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—GSTP1—bone cancer	1.55e-05	0.00015	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—EGFR—bone cancer	1.55e-05	0.00015	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—KIT—bone cancer	1.55e-05	0.00015	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—EGFR—bone cancer	1.53e-05	0.000149	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—EGFR—bone cancer	1.53e-05	0.000149	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—BRAF—bone cancer	1.53e-05	0.000148	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—BRAF—bone cancer	1.52e-05	0.000148	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—JUN—bone cancer	1.5e-05	0.000146	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—JUN—bone cancer	1.5e-05	0.000146	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—JUN—bone cancer	1.49e-05	0.000145	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MDM2—bone cancer	1.49e-05	0.000145	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.48e-05	0.000144	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—BRAF—bone cancer	1.48e-05	0.000144	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.47e-05	0.000143	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MDM2—bone cancer	1.47e-05	0.000143	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MDM2—bone cancer	1.47e-05	0.000143	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MMP9—bone cancer	1.46e-05	0.000142	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MMP9—bone cancer	1.46e-05	0.000142	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—JUN—bone cancer	1.46e-05	0.000142	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—BRAF—bone cancer	1.45e-05	0.000141	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MMP9—bone cancer	1.45e-05	0.000141	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.44e-05	0.00014	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.44e-05	0.00014	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—JUN—bone cancer	1.44e-05	0.00014	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—EGFR—bone cancer	1.43e-05	0.000139	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PTGS2—bone cancer	1.43e-05	0.000139	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—KIT—bone cancer	1.43e-05	0.000139	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MMP9—bone cancer	1.42e-05	0.000138	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ENO2—bone cancer	1.42e-05	0.000138	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—EGFR—bone cancer	1.41e-05	0.000137	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—KIT—bone cancer	1.4e-05	0.000136	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MMP9—bone cancer	1.4e-05	0.000136	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—KIT—bone cancer	1.37e-05	0.000134	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—JUN—bone cancer	1.37e-05	0.000133	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—BRAF—bone cancer	1.34e-05	0.00013	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MDM2—bone cancer	1.34e-05	0.00013	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MMP9—bone cancer	1.33e-05	0.00013	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MDM2—bone cancer	1.33e-05	0.000129	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—BRAF—bone cancer	1.32e-05	0.000128	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—DHFR—bone cancer	1.32e-05	0.000128	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—EGFR—bone cancer	1.3e-05	0.000126	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—JUN—bone cancer	1.29e-05	0.000126	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.29e-05	0.000126	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—TP53—bone cancer	1.28e-05	0.000125	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MDM2—bone cancer	1.28e-05	0.000124	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.28e-05	0.000124	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—KIT—bone cancer	1.28e-05	0.000124	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—JUN—bone cancer	1.28e-05	0.000124	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—JUN—bone cancer	1.28e-05	0.000124	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MDM2—bone cancer	1.27e-05	0.000124	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MMP9—bone cancer	1.26e-05	0.000122	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.25e-05	0.000122	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MMP9—bone cancer	1.24e-05	0.000121	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MMP9—bone cancer	1.24e-05	0.000121	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MDM2—bone cancer	1.24e-05	0.00012	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GSTP1—bone cancer	1.24e-05	0.00012	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GNA11—bone cancer	1.23e-05	0.00012	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MDM2—bone cancer	1.22e-05	0.000118	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—BRAF—bone cancer	1.2e-05	0.000117	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—EGFR—bone cancer	1.18e-05	0.000115	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—EGFR—bone cancer	1.18e-05	0.000115	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—EGFR—bone cancer	1.17e-05	0.000114	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	1.16e-05	0.000113	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—JUN—bone cancer	1.16e-05	0.000113	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PTGS2—bone cancer	1.16e-05	0.000113	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—JUN—bone cancer	1.15e-05	0.000112	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—EGFR—bone cancer	1.15e-05	0.000112	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MMP9—bone cancer	1.13e-05	0.00011	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—EGFR—bone cancer	1.13e-05	0.00011	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MDM2—bone cancer	1.12e-05	0.000109	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MMP9—bone cancer	1.12e-05	0.000109	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—JUN—bone cancer	1.11e-05	0.000108	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—JUN—bone cancer	1.11e-05	0.000108	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MDM2—bone cancer	1.11e-05	0.000107	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MDM2—bone cancer	1.08e-05	0.000105	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MMP9—bone cancer	1.08e-05	0.000105	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—EGFR—bone cancer	1.08e-05	0.000105	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MMP9—bone cancer	1.08e-05	0.000105	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—JUN—bone cancer	1.08e-05	0.000105	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—JUN—bone cancer	1.06e-05	0.000103	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MMP9—bone cancer	1.05e-05	0.000102	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MMP9—bone cancer	1.03e-05	0.0001	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—EGFR—bone cancer	1.02e-05	9.88e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MDM2—bone cancer	1.01e-05	9.78e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—EGFR—bone cancer	1e-05	9.75e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—EGFR—bone cancer	1e-05	9.75e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—bone cancer	9.91e-06	9.64e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—bone cancer	9.9e-06	9.63e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—bone cancer	9.84e-06	9.57e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—JUN—bone cancer	9.76e-06	9.49e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—bone cancer	9.63e-06	9.37e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—JUN—bone cancer	9.6e-06	9.34e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTP1—bone cancer	9.53e-06	9.27e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MMP9—bone cancer	9.5e-06	9.23e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—bone cancer	9.48e-06	9.22e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—JUN—bone cancer	9.4e-06	9.14e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MMP9—bone cancer	9.34e-06	9.09e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MMP9—bone cancer	9.15e-06	8.9e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EGFR—bone cancer	9.14e-06	8.89e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EGFR—bone cancer	9.05e-06	8.8e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—bone cancer	9.05e-06	8.8e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EGFR—bone cancer	8.74e-06	8.5e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—JUN—bone cancer	8.74e-06	8.5e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EGFR—bone cancer	8.7e-06	8.46e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—bone cancer	8.53e-06	8.3e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MMP9—bone cancer	8.5e-06	8.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EGFR—bone cancer	8.46e-06	8.22e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—bone cancer	8.42e-06	8.19e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—bone cancer	8.42e-06	8.19e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EGFR—bone cancer	8.32e-06	8.09e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTGS2—bone cancer	8.01e-06	7.79e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EGFR—bone cancer	7.67e-06	7.46e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—bone cancer	7.67e-06	7.46e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—bone cancer	7.6e-06	7.39e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EGFR—bone cancer	7.55e-06	7.34e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EGFR—bone cancer	7.39e-06	7.19e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—bone cancer	7.34e-06	7.14e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—bone cancer	7.3e-06	7.1e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—bone cancer	7.1e-06	6.91e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—bone cancer	6.99e-06	6.8e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EGFR—bone cancer	6.87e-06	6.68e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—bone cancer	6.44e-06	6.27e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTGS2—bone cancer	6.4e-06	6.22e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—bone cancer	6.34e-06	6.16e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—bone cancer	6.21e-06	6.04e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—bone cancer	5.77e-06	5.61e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS2—bone cancer	4.94e-06	4.8e-05	CbGpPWpGaD
